EFFECT OF REPLICATE DESIGN ON DRUG VARIABILITY AND BIOEQUIVALENCE IN HUMANS
variability should be sufficient to justify using wider acceptance limits of 75-133 %. PDF HTML
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
variability should be sufficient to justify using wider acceptance limits of 75-133 %. PDF HTML
same main characteristics and statistical procedures as for the prolonged release formulations PDF HTML
where rapid absorption is of importance as recommended by the draft EMEA guideline. PDF HTML
will demonstrate link between BA/BE and the newly emerged science of Pharmacogenetics. PDF HTML
formulations are bioequivalent in terms of rate and extent of drug absorption. PDF HTML
maternal to fetal direction and their effect on placental tissue functions. PDF HTML
investigate the potential of novel nanoemulsion formulations for the transdermal delivery of ropinirole PDF HTML
therapeutics in pregnancy will be discussed including potential toxicity of nanoparticles in pregnancy. PDF HTML
local experience performed to assess a new insulin biosimilar product for clinical use PDF HTML
story, the pathology, the indication, the dosage and the product complexity PDF HTML
will elaborate on frequent issues encountered by the SAWP in this context. PDF HTML
ADME prognosis and successful validation using the leave-one-out (LOO) procedures. PDF HTML
related to change in formulation of epoetin alfa produced outside the United States PDF HTML
high connectivity in interaction network). Similarly, other potential combinations have good target profile PDF HTML
highly variable drugs, and to satisfy the internationally suggested guideline in bioequivalence PDF HTML
symmetric precision in log scale was recommended in sizing pediatric BA studies PDF HTML
WinNonlin) can be different owing to model optimization and treatment of missing data PDF HTML
Plant Secondary Metabolism Engineering Methods and Applications. Totowa, NJ: Humana Press Inc.; 2010 PDF HTML
proposed method was simple, highly sensitive, precise, accurate and repeatable. PDF HTML
lead to improved oral bioavailability due to enhanced solubility, permeation and, thus absorption PDF HTML
challenges of bioavailability and bioequivalence of complex products in the 21 st century PDF HTML
Bioequivalence was confirmed with a power greater than 90%. PDF HTML
sanctuaries. Pilot scale up of prepared nanosuspensions confirmed the suitability for commercialization. PDF HTML
regulatory guidelines in the areas of novel and targeted drug delivery systems PDF HTML
plasma, thereby giving more insight about the pharmacokinetics of the drug in human PDF HTML
For authors and organisers
Find the right journal for your paper and submit your manuscript.